Moreover, overexpression of APP causes memory impairment without Aβ deposition in some App transgenic mice [8, 11], suggesting that the brains of these transgenic mouse models may have pathophysiological properties that are not relevant to AD pathogenesis. This evidence concerns the gene APP and Alzheimer disease.